The up-regulation and nuclear localization of YAP1 has been shown to correlate with progression, metastasis and poor patient outcome in several cancers, such as non small cell lung cancer, breast cancer, gastric carcinoma and hepatocellular carcinoma[32-34, 56-58]. This evidence concerns the gene YAP1 and breast cancer.